Put Options

17 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$41.19 - $49.72 $11.2 Million - $13.5 Million
272,500 Added 990.91%
300,000 $13.3 Million
Q2 2024

Aug 14, 2024

SELL
$27.55 - $48.83 $2.76 Million - $4.88 Million
-100,000 Reduced 78.43%
27,500 $1.19 Million
Q1 2024

May 15, 2024

BUY
$21.32 - $34.81 $2.72 Million - $4.44 Million
127,500 New
127,500 $3.73 Million
Q2 2023

Aug 14, 2023

BUY
$21.38 - $29.19 $641,400 - $875,700
30,000 Added 100.0%
60,000 $1.7 Million
Q4 2022

Feb 14, 2023

SELL
$24.81 - $31.52 $2.11 Million - $2.68 Million
-85,000 Reduced 73.91%
30,000 $842,000
Q3 2022

Nov 14, 2022

BUY
$19.51 - $34.14 $2.24 Million - $3.93 Million
115,000 New
115,000 $3.25 Million
Q2 2022

Aug 15, 2022

SELL
$17.06 - $31.42 $980,949 - $1.81 Million
-57,500 Closed
0 $0
Q1 2022

May 13, 2022

SELL
$26.68 - $34.81 $133,400 - $174,050
-5,000 Reduced 8.0%
57,500 $1.68 Million
Q4 2021

Feb 11, 2022

BUY
$29.58 - $49.78 $1.85 Million - $3.11 Million
62,500 New
62,500 $2.06 Million
Q3 2021

Nov 12, 2021

SELL
$41.92 - $58.18 $2.1 Million - $2.91 Million
-50,000 Closed
0 $0
Q2 2021

Aug 16, 2021

BUY
$52.06 - $61.27 $1.3 Million - $1.53 Million
25,000 Added 100.0%
50,000 $2.76 Million
Q4 2020

Feb 16, 2021

SELL
$33.21 - $46.54 $830,250 - $1.16 Million
-25,000 Reduced 50.0%
25,000 $1.08 Million
Q3 2020

Nov 16, 2020

SELL
$33.87 - $55.93 $338,700 - $559,300
-10,000 Reduced 16.67%
50,000 $1.75 Million
Q2 2020

Aug 14, 2020

BUY
$34.45 - $53.48 $1.6 Million - $2.49 Million
46,500 Added 344.44%
60,000 $3.21 Million
Q1 2020

May 15, 2020

SELL
$31.52 - $53.81 $47,280 - $80,715
-1,500 Reduced 10.0%
13,500 $478,000
Q4 2019

Feb 13, 2020

SELL
$30.08 - $50.59 $5.59 Million - $9.41 Million
-186,000 Reduced 92.54%
15,000 $716,000
Q3 2019

Nov 14, 2019

BUY
$32.4 - $49.58 $6.51 Million - $9.97 Million
201,000 New
201,000 $6.51 Million

Others Institutions Holding AGIO

About AGIOS PHARMACEUTICALS, INC.


  • Ticker AGIO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 54,818,000
  • Market Cap $3.24B
  • Description
  • Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...
More about AGIO
Track This Portfolio

Track Caption Management, LLC Portfolio

Follow Caption Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Caption Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Caption Management, LLC with notifications on news.